Related references
Note: Only part of the references are listed.Liver transplantation for HBV-related cirrhosis in Europe: An ELTR study on evolution and outcomes
Patrizia Burra et al.
JOURNAL OF HEPATOLOGY (2013)
Entecavir Monotherapy Is Effective in Suppressing Hepatitis B Virus After Liver Transplantation
James Fung et al.
GASTROENTEROLOGY (2011)
Efficacy and Safety of Entecavir and/or Tenofovir for Prophylaxis and Treatment of Hepatitis B Recurrence Post-Liver Transplant
M. Jimenez-Perez et al.
TRANSPLANTATION PROCEEDINGS (2010)
The role of entecavir in preventing hepatitis B recurrence after liver transplantation
Zhi Feng Xi et al.
JOURNAL OF DIGESTIVE DISEASES (2009)
A Randomized Study of Adefovir Dipivoxil in Place of HBIG in Combination with Lamivudine As Post-Liver Transplantation Hepatitis B Prophylaxis
Peter W. Angus et al.
HEPATOLOGY (2008)
Identification of hepatitis B virus-specific lymphocytes in human liver grafts from HBV-immune donors
Ying Luo et al.
LIVER TRANSPLANTATION (2007)
Outcome of liver transplantation for hepatitis B in the United States
WR Kim et al.
LIVER TRANSPLANTATION (2004)
Development of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis B
CM Lo et al.
HEPATOLOGY (2003)
Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched, untreated cohort
FY Yao et al.
HEPATOLOGY (2001)
Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B
PW Angus et al.
LIVER TRANSPLANTATION (2000)
Share Paper
